Investigation of nanostructured lipid carriers for fast intracellular localization screening using the Echo liquid handler.

Autor: Glader C; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: christina.glader@rcpe.at., Jeitler R; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: ramona.jeitler@uni-graz.at., Stanzer S; CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Austria; Medical University of Graz, Division of Oncology, Department of Internal Medicine, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: stefanie.stanzer@cbmed.at., Harbusch N; CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Austria. Electronic address: nora.harbusch@cbmed.at., Prietl B; CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Austria; Medical University of Graz, Division of Endocrinology and Diabetology, Department of Internal Medicine, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: barbara.prietl@cbmed.at., El-Heliebi A; CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Austria; Medical University of Graz, Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Neue Stiftingtalstraße 6, 8010 Graz, Austria. Electronic address: amin.elheliebi@cbmed.at., Selmani A; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: atida.selmani@uni-graz.at., Fröhlich E; Medical University of Graz, Center for Medical Research, Stiftingtalstraße 24, 8010 Graz, Austria. Electronic address: eleonore.froehlich@medunigraz.at., Mussbacher M; University of Graz, Institute of Pharmaceutical Sciences, Pharmacology & Toxicology, Humboldtstraße 46, 8010 Graz, Austria. Electronic address: marion.mussbacher@uni-graz.at., Roblegg E; Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: eva.roblegg@uni-graz.at.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2024 Nov 15; Vol. 665, pp. 124698. Date of Electronic Publication: 2024 Sep 12.

Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus [Poster]

Autor: Bauernhofer, T., Stanzer, S., Prietl, B., Kofler, S., Obermayer-Pietsch, B., Pichler, Martin, Sourij, H., Pieber, T.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3341::9e49df72865e162b2af7f30ed69ad091
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/101723

339 - Psychoneuroimmunological predictors of breast cancer progression

Autor: Andritsch, E., Farkas, C., Stanzer, S., Bauernhofer, T., Vigier, M.

Publikováno v: In Journal of Psychosomatic Research June 2020 133

48P - Genetic and Epigenetic Heterogeneity of Putative Breast Cancer Stem Cells

Autor: Balic, M., Stanzer, S., Heitzer, E., Schwarzenbacher, D., Auer, M., Geigl, J.B., Datar, R.H., Dandachi, N.

Publikováno v: In Annals of Oncology May 2013 24 Supplement 3:iii25-iii25

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.

Autor: Barth DA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Stanzer S; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Spiegelberg JA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Bauernhofer T; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Absenger G; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Szkandera J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Gerger A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Smolle MA; Department of Orthopaedics and Trauma, Medical University of Graz, Graz, Austria., Hutterer GC; Department of Urology, Medical University of Graz, Graz, Austria., Ahyai SA; Department of Urology, Medical University of Graz, Graz, Austria., Madl T; Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.; BioTechMed-Graz, Graz, Austria., Posch F; Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Riedl JM; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Klec C; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Jost PJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Kargl J; Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Graz, Austria., Stradner MH; Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Apr 01; Vol. 13, pp. 840207. Date of Electronic Publication: 2022 Apr 01 (Print Publication: 2022).